DiaSorin S.p.A. (BIT:DIA)
64.24
+1.38 (2.20%)
May 7, 2026, 5:37 PM CET
DiaSorin Revenue
In the year 2025, DiaSorin had annual revenue of 1.20B EUR with 0.81% growth. DiaSorin had revenue of 295.06M in the quarter ending December 31, 2025, a decrease of -4.64%.
Revenue (ttm)
1.19B
Revenue Growth
+0.73%
P/S Ratio
2.85
Revenue / Employee
368.62K
Employees
3,272
Market Cap
3.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20B | 9.63M | 0.81% |
| Dec 31, 2024 | 1.19B | 37.22M | 3.24% |
| Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
| Dec 31, 2022 | 1.36B | 123.49M | 9.98% |
| Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
| Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
| Dec 31, 2019 | 706.32M | 37.12M | 5.55% |
| Dec 31, 2018 | 669.20M | 31.71M | 4.97% |
| Dec 31, 2017 | 637.49M | 68.18M | 11.97% |
| Dec 31, 2016 | 569.31M | 70.13M | 14.05% |
| Dec 31, 2015 | 499.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.39B |
| Safilo Group | 983.38M |
| EL.En. | 590.85M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 485.12M |
| Philogen | 319.73M |
| Svas Biosana | 134.95M |
DiaSorin News
- 6 weeks ago - DiaSorin Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - DiaSorin Earnings Call Transcript: Q3 2025 - Transcripts
- 10 months ago - DiaSorin Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - DiaSorin Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Italy's DiaSorin ex-Covid revenue in line with guidance - Reuters
- 1 year ago - DiaSorin Earnings Call Transcript: Q4 2024 - Transcripts
- 1 year ago - DiaSorin Earnings Call Transcript: Q3 2024 - Transcripts
- 1 year ago - Diagnostics group DiaSorin's nine-month adjusted core profit up 6% - Reuters